ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 255 filers reported holding ABERDEEN STD GOLD ETF TR in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $851,774 | -3.7% | 48,150 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $884,516 | -2.6% | 48,150 | 0.0% | 0.02% | -5.9% |
| Q1 2023 | $908,591 | +8.0% | 48,150 | 0.0% | 0.02% | +6.2% |
| Q4 2022 | $841,181 | +9.7% | 48,150 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $767,000 | -8.0% | 48,150 | 0.0% | 0.02% | +6.7% |
| Q2 2022 | $834,000 | -6.8% | 48,150 | 0.0% | 0.02% | +7.1% |
| Q1 2022 | $895,000 | +5.8% | 48,150 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $846,000 | +4.3% | 48,150 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $811,000 | -0.9% | 48,150 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $818,000 | +3.5% | 48,150 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $790,000 | -10.2% | 48,150 | 0.0% | 0.01% | -20.0% |
| Q4 2020 | $880,000 | +14.3% | 48,150 | +13.4% | 0.02% | 0.0% |
| Q3 2020 | $770,000 | +53.7% | 42,450 | +45.1% | 0.02% | +50.0% |
| Q2 2020 | $501,000 | +173.8% | 29,250 | +141.7% | 0.01% | +100.0% |
| Q1 2020 | $183,000 | – | 12,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudock, Inc. | 1,147,876 | $18,825,000 | 5.89% |
| UBP Investment Advisors SA | 716,194 | $11,750,000 | 4.80% |
| swisspartners Ltd. | 305,000 | $5,011,000 | 4.07% |
| Darwin Wealth Management, LLC | 1,380,786 | $22,644,000 | 3.95% |
| Cypress Capital, LLC | 527,505 | $8,651,000 | 3.53% |
| Newman Dignan & Sheerar, Inc. | 430,281 | $7,057,000 | 2.56% |
| SimpliFi, Inc. | 318,301 | $5,220,000 | 2.44% |
| Allen Capital Group, LLC | 577,017 | $9,463,000 | 2.08% |
| Almanack Investment Partners, LLC. | 1,191,188 | $19,536,000 | 1.99% |
| American Money Management, LLC | 314,165 | $5,152,000 | 1.92% |